Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1535806

Cover Image

PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1535806

Singapore Diagnostic Labs Market Size- By Provider Type, By Test Type, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

PUBLISHED:
PAGES: 108 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 2950
PDF (Group License)
USD 3950
PDF (Company License)
USD 5150

Add to Cart

Singapore Diagnostic Labs Market Introduction and Overview

According to SPER Market Research, 'Singapore Diagnostic Labs Market Size - By Provider Type, By Test Type, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2033' States that the Singapore Diagnostic Labs Market is estimated to reach USD 1416.13 million by 2033 with a CAGR of 7.16%.

A diagnostic laboratory is a facility (or a section within a facility) that is furnished with the tools and supplies needed to perform tests for infections in humans. Clinical diagnostics are important in the diagnosis of common chronic illnesses as well as in the prevention, identification, and treatment of disease. By helping to identify specific risk factors and early warning indicators, clinical diagnostics create new opportunities for early intervention and prevention.

The COVID-19 pandemic highlighted the significance of diagnosis and treatment while also changing the scope and capabilities of the diagnostic sector. Point-of-care testing (PoCT) and home sample collection saw a rise in consumer usage. Diagnostic laboratories have also begun to provide diagnoses to patients at their homes, analogous to online consultations carried out with the use of telehealth and telemedicine services.

Scope of the report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Provider Type, By Test Type, By End User.

Regions covered Western, Southern, Eastern, Northern, Central.

Companies Covered Singapore Medical Group, Raffles Medical Group, Parkway Laboratory Services Ltd, National Healthcare Group, Pathology & Clinical Laboratory Pte Ltd, Reste Group, Biolidics Limited, Acumen Diagnostics Pte Ltd.

Singapore Diagnostic Labs Market Segmentation

By Provider Type: Based on the Provider Type, Singapore Diagnostic Labs Market is segmented as; Stand-Alone Diagnostic Labs, Hospital-Based Diagnostic Labs, Diagnostic Chains.

By Test Type: Based on the Test Type, Singapore Diagnostic Labs Market is segmented as; Pathology, Radiology.

By End User: Based on the End User, Singapore Diagnostic Labs Market is segmented as; Referrals, Walk-ins, Corporate Clients.

By Region: This research also includes data for Western, Southern, Eastern, Northern, Central.

Product Code: HLCA2467

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPER's internal database
    • 2.1.4. Premium insight from KOL's
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity, and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges
  • 4.2. COVID-19 Impacts of the Singapore Diagnostic Labs Market

5. Market variable and outlook

  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4. Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTER's Five Forces
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat Map Analysis

6. Competitive Landscape

  • 6.1. Singapore Diagnostic Labs Market Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Singapore Diagnostic Labs Market

7. Singapore Diagnostic Labs Market, By Provider Type (USD Million) 2020-2033

  • 7.1. Singapore Diagnostic Labs Market Size, Share and Forecast, By Provider Type, 2020-2026
  • 7.2. Singapore Diagnostic Labs Market Size, Share and Forecast, By Provider Type, 2027-2033
  • 7.3. Stand-Alone Diagnostic Labs
  • 7.4. Hospital-Based Diagnostic Labs
  • 7.5. Diagnostic Chains

8. Singapore Diagnostic Labs Market, By Test Type (USD Million) 2020-2033

  • 8.1. Singapore Diagnostic Labs Market Size, Share and Forecast, By Test Type, 2020-2026
  • 8.2. Singapore Diagnostic Labs Market Size, Share and Forecast, By Test Type, 2027-2033
  • 8.3. Pathology
  • 8.4. Radiology

9. Singapore Diagnostic Labs Market, By Construction (USD Million) 2020-2033

  • 9.1. Singapore Diagnostic Labs Market Size, Share and Forecast, By End User, 2020-2026
  • 9.2. Singapore Diagnostic Labs Market Size, Share and Forecast, By End User, 2027-2033
  • 9.3. Referrals
  • 9.4. Walk-ins
  • 9.5. Corporate Clients

10. Singapore Diagnostic Labs Market Forecast, 2020-2033 (USD Million)

  • 10.1. Singapore Diagnostic Labs Market Size and Market Share

11. Singapore Diagnostic Labs Market, By Region, 2020-2033 (USD Million)

  • 11.1. Singapore Diagnostic Labs Market Size and Market Share By Region (2020-2026)
  • 11.2. Singapore Diagnostic Labs Market Size and Market Share By Region (2027-2033)
  • 11.3. Western
  • 11.4. Southern
  • 11.5. Eastern
  • 11.6. Northern
  • 11.7. Central

12. Company Profile

  • 12.1. Singapore Medical Group
    • 12.1.1. Company details
    • 12.1.2. Financial outlook
    • 12.1.3. Product summary
    • 12.1.4. Recent developments
  • 12.2. Raffles Medical Group
    • 12.2.1. Company details
    • 12.2.2. Financial outlook
    • 12.2.3. Product summary
    • 12.2.4. Recent developments
  • 12.3. Parkway Laboratory Services Ltd.
    • 12.3.1. Company details
    • 12.3.2. Financial outlook
    • 12.3.3. Product summary
    • 12.3.4. Recent developments
  • 12.4. National Healthcare Group
    • 12.4.1. Company details
    • 12.4.2. Financial outlook
    • 12.4.3. Product summary
    • 12.4.4. Recent developments
  • 12.5. Pathology & Clinical Laboratory Pte Ltd
    • 12.5.1. Company details
    • 12.5.2. Financial outlook
    • 12.5.3. Product summary
    • 12.5.4. Recent developments
  • 12.6. Reste Group
    • 12.6.1. Company details
    • 12.6.2. Financial outlook
    • 12.6.3. Product summary
    • 12.6.4. Recent developments
  • 12.7. Biolidics Limited
    • 12.7.1. Company details
    • 12.7.2. Financial outlook
    • 12.7.3. Product summary
    • 12.7.4. Recent developments
  • 12.8. Acumen Diagnostics Pte. Ltd.
    • 12.8.1. Company details
    • 12.8.2. Financial outlook
    • 12.8.3. Product summary
    • 12.8.4. Recent developments
  • 12.9. Others

13. Conclusion

14. List of Abbreviations

15. Reference Links

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!